Guang Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Guang Yang has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Chenghu Wang
Neonatal Internal Medicine, Children's Hospital of Shanxi, PR China
1 shared publication - Guang Yang
Neonatal Center, Beijing Children's Hospital, Capital Medical University, Beijing
1 shared publication - J. Zhao
Department of Pharmacy, Shanxi Children's Hospital, Taiyuan, China
1 shared publication Jie Zhao
Children's Hospital of Shanxi
1 shared publication- M.E. Gao
Department of Pharmacy, Shanxi Children's Hospital, Taiyuan, China
1 shared publication Minge Gao
Children's Hospital of Shanxi
1 shared publication
Latest Publications
- Open Access
- 31 January 2024
- Published by Wiley
Investigation on Knowledge Level of Rational Application of Antimicrobial Drug among Pharmacists in Medical Institutions in China's Shanxi province
OBJECTIVE: To investigate the knowledge of rational use of antibiotics among pharmacists in medical institutions in China’s Shanxi province, so as to find out the problems, then to provide support for the management of antibiotics. METHODS: A questionnaire survey was conducted, which included the basic information of the respondents, the basic knowledge of antimicrobial management and the related knowledge of antimicrobial. SPSS 25.0 was used for statistical analysis. RESULTS: 462 pharmacists were investigated. The average score of the knowledge related to rational use of antibiotics was (10.49±4.05). It showed that the hospital type, grade, pharmacist’s education, professional title and working years all had effect on the pharmacists’ mastery of antimicrobial related knowledge (P<0.05). Multivariate logistic regression analysis showed that hospital grade and pharmacist’s education were the main influencing factors (P<0.05). CONCLUSION: Pharmacists have insufficient knowledge about the rational application of antibacterial drugs. It is essential to strengthen the training of management regulations and application of antibacterial drugs.
- 31 January 2024
- Published by Wiley
Open AccessInvestigation on Knowledge Level of Rational Application of Antimicrobial Drug among Pharmacists in Medical Institutions in China's Shanxi province
OBJECTIVE: To investigate the knowledge of rational use of antibiotics among pharmacists in medical institutions in China’s Shanxi province, so as to find out the problems, then to provide support for the management of antibiotics. METHODS: A questionnaire survey was conducted, which included the basic information of the respondents, the basic knowledge of antimicrobial management and the related knowledge of antimicrobial. SPSS 25.0 was used for statistical analysis. RESULTS: 462 pharmacists were investigated. The average score of the knowledge related to rational use of antibiotics was (10.49±4.05). It showed that the hospital type, grade, pharmacist’s education, professional title and working years all had effect on the pharmacists’ mastery of antimicrobial related knowledge (P<0.05). Multivariate logistic regression analysis showed that hospital grade and pharmacist’s education were the main influencing factors (P<0.05). CONCLUSION: Pharmacists have insufficient knowledge about the rational application of antibacterial drugs. It is essential to strengthen the training of management regulations and application of antibacterial drugs.
- 12 July 2022
- Published by Elsevier in Public Health
- Vol. 209, 67-72
Investigation on knowledge level about rational use of antimicrobial drugs among pharmacists in medical institutions in Shanxi province, China
- 12 July 2022
- Published by Elsevier in Public Health
- Vol. 209, 67-72
Investigation on knowledge level about rational use of antimicrobial drugs among pharmacists in medical institutions in Shanxi province, China
- Open Access
- 1 February 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (9) , e19216
Effects of less invasive surfactant administration (LISA) via a gastric tube on the treatment of respiratory distress syndrome in premature infants aged 32 to 36 weeks
To explore the clinical effects of less invasive surfactant administration (LISA) via a gastric tube on the treatment of respiratory distress syndrome (RDS) in premature infants aged 32 to 36 weeks. A total of 97 premature infants with RDS admitted to the Children's Hospital of Shanxi from February 2017 to January 2018 were randomly divided into LISA (47 cases) and (intubation-surfactant-extubation,) INSURE groups (50 cases). In the LISA group, 6F gastric tubes were inserted into the trachea through direct laryngoscopy under nasal continuous positive airway pressure (NCPAP), and pulmonary surfactant (PS) was injected. In the INSURE group, PS was injected via tracheal intubation and NCPAP was performed after extubation. The incidence of technical-related adverse events and various complications in the two groups were observed. PS was successfully injected through gastric tube in the LISA group. There were no significant differences in reflux, asphyxia, bradycardia (2, changes in PaO2 and PaCO2 at 1 hour post-treatment between the groups. During the course of administration, blood pressure and SpO2 in the LISA group were more stable, and significant differences between the 2 groups were observed. However, no significant differences in the complications and outcomes between the 2 groups occurred. The LISA technique can be used to treat premature infants with RDS aged 32 to 36 weeks with stronger spontaneous breathing ability. Further clinical studies are required to determine the optimal strategy of LISA administration and the most profitable patient population.
- 1 February 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (9) , e19216
Open AccessEffects of less invasive surfactant administration (LISA) via a gastric tube on the treatment of respiratory distress syndrome in premature infants aged 32 to 36 weeks
To explore the clinical effects of less invasive surfactant administration (LISA) via a gastric tube on the treatment of respiratory distress syndrome (RDS) in premature infants aged 32 to 36 weeks. A total of 97 premature infants with RDS admitted to the Children's Hospital of Shanxi from February 2017 to January 2018 were randomly divided into LISA (47 cases) and (intubation-surfactant-extubation,) INSURE groups (50 cases). In the LISA group, 6F gastric tubes were inserted into the trachea through direct laryngoscopy under nasal continuous positive airway pressure (NCPAP), and pulmonary surfactant (PS) was injected. In the INSURE group, PS was injected via tracheal intubation and NCPAP was performed after extubation. The incidence of technical-related adverse events and various complications in the two groups were observed. PS was successfully injected through gastric tube in the LISA group. There were no significant differences in reflux, asphyxia, bradycardia (2, changes in PaO2 and PaCO2 at 1 hour post-treatment between the groups. During the course of administration, blood pressure and SpO2 in the LISA group were more stable, and significant differences between the 2 groups were observed. However, no significant differences in the complications and outcomes between the 2 groups occurred. The LISA technique can be used to treat premature infants with RDS aged 32 to 36 weeks with stronger spontaneous breathing ability. Further clinical studies are required to determine the optimal strategy of LISA administration and the most profitable patient population.